Prestige® Prodigy

For vaccination of healthy horses 6 months of age or older, as an aid in the prevention of abortion and respiratory disease caused by equine herpesvirus type 1 (EHV-1) infection.

The Science of Protected

  • EHV-1, or rhino, can cause respiratory tract infections, epidemic abortions in mares, the birth of non-viable foals and sporadic neurological disease. This vaccine does not have a label claim for neurological disease protection.
  • An inactivated, purified, concentrated, adjuvanted, tissue culture origin, equine herpesvirus EHV-1 vaccine
  • Exceptional safety profile with the smooth Havlogen® adjuvant
  • Advanced filtration process through the Antigen Purification System (APS)


Additional Resources



For pregnant mares administer a 2 mL dose intramuscularly in the 5th, 7th and 9th months of pregnancy. Three doses are essential for primary immunization. Maiden and barren mares housed or pastured with pregnant mares should be vaccinated on the same schedule. For primary vaccination against respiratory disease administer three 2 mL doses intramuscularly at 4 to 6 week intervals. A 2 mL booster dose should be administered annually and at any time epidemic conditions exist or are reported and exposure is imminent.